Cargando…
How to Make Anticancer Drugs Cross the Blood–Brain Barrier to Treat Brain Metastases
The incidence of brain metastases has increased in the last 10 years. However, the survival of patients with brain metastases remains poor and challenging in daily practice in medical oncology. One of the mechanisms suggested for the persistence of a high incidence of brain metastases is the failure...
Autores principales: | Angeli, Eurydice, Nguyen, Thuy T., Janin, Anne, Bousquet, Guilhem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981899/ https://www.ncbi.nlm.nih.gov/pubmed/31861465 http://dx.doi.org/10.3390/ijms21010022 |
Ejemplares similares
-
Brain Metastasis Treatment: The Place of Tyrosine Kinase Inhibitors and How to Facilitate Their Diffusion across the Blood–Brain Barrier
por: Angeli, Eurydice, et al.
Publicado: (2021) -
Genomics of Breast Cancer Brain Metastases: A Meta-Analysis and Therapeutic Implications
por: Nguyen, Thuy Thi, et al.
Publicado: (2023) -
The Pharmacology of Xenobiotics after Intracerebro Spinal Fluid Administration: Implications for the Treatment of Brain Tumors
por: Paris, Justine, et al.
Publicado: (2021) -
A Boom in Nanotechnologies for a High Level of Precision Medicine
por: Angeli, Eurydice, et al.
Publicado: (2023) -
HER2 Amplification Level Predicts Pathological Complete Response in the Neoadjuvant Setting of HER2-Overexpressing Breast Cancer: A Meta-Analysis and Systematic Review
por: Gonullu, Burak, et al.
Publicado: (2023)